Status:
ACTIVE_NOT_RECRUITING
Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Canadian Cancer Trials Group
Princess Margaret Hospital, Canada
Conditions:
Cervix Neoplasms
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with carcinoma of the cervix ( 3 cm in size or larger) where an examination under anesthesia is to be performed for staging purposes
- Informed consent
Exclusion
- Patients with clinically occult cervix carcinoma
Key Trial Info
Start Date :
December 1 1995
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00188539
Start Date
December 1 1995
End Date
December 1 2027
Last Update
February 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9